According to Aytu BioScience
's latest financial reports the company has a price-to-book ratio of 0.5152.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.4813 | 86.89% |
2022-12-31 | 0.2575 | -28.48% |
2021-12-31 | 0.3601 | -60.66% |
2020-12-31 | 0.9152 | -22.43% |
2019-12-31 | 1.18 | 182.02% |
2018-12-31 | 0.4183 | -88.39% |
2017-12-31 | 3.60 | 189.29% |
2016-12-31 | 1.25 | -64.44% |
2015-12-31 | 3.50 | |
2014-12-31 | N/A | -100% |
2013-12-31 | -13.6 | -67.04% |
2012-12-31 | -41.3 | -46.05% |
2011-12-31 | -76.5 | 804.69% |
2010-12-31 | -8.46 | -84.5% |
2009-12-31 | -54.6 | |
2008-12-31 | N/A | |
2007-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Rollins ROL | 19.6 | 3,700.84% | ๐บ๐ธ USA |
Stride (K12 Education)
LRN | 2.65 | 414.01% | ๐บ๐ธ USA |